# Sunshine Biopharma Inc.: Form 8-K, filed Oct 20, 2023

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2023-10-20
- Accepted by EDGAR: Oct 20, 2023, 13:06 ET
- Period: 2023-10-18
- Accession: 0001683168-23-007302
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007302/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316823007302/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316823007302/sunshine_8k.htm

Filed Oct 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-007302. Last ingested by Listed: Nov 11, 2026, 03:50 ET. No prices; not investment advice.